Amicus Therapeutics Inc. buy UBS Group AG
Start price
10.05.24
/
50%
€8.60
Target price
10.05.25
€17.63
Performance (%)
-37.79%
End price
11.05.25
€5.35
Summary
This prediction ended on 11.05.25 with a price of €5.35. Massive losses of -37.79% were the result for the BUY prediction by UBS_Group_AG. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -3.306% | -3.306% | 27.174% |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% |
Comments by UBS_Group_AG for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at UBS Group AG from $20.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
02.03.23
02.03.23
€16.05
02.03.24
02.03.24
0.83%
03.03.24
03.03.24
